Clinical laboratory tests: Application to daily practice

Journal of the American Pharmaceutical Association

Volumn 36, Issue 11, 1996, Pages 668-679

  Cannon, B ^a   Lee, M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNINDEXED DRUG;

ADVERSE DRUG REACTION; DRUG MONITORING; DRUG THERAPY; LABORATORY TEST; PHARMACIST; REVIEW; DIAGNOSIS, MEASUREMENT AND ANALYSIS; HUMAN; PHARMACY;

DRUG THERAPY; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; PHARMACEUTICAL SERVICES;

EID: 0029906911     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1086-5802(16)30152-8     Document Type: Review

References (13)

1. J.E. Oesterling S.K. Martin E.J. Bergstralh The use of prostatespecific antigen in staging patients with newly diagnosed prostate cancer JAMA. 269 1993 57 60
2. O.K. Wysowski J.P. Freiman J.B. Tourtelot Fatal and nonfatal hepato-toxicity associated with flutamide Ann Intern Med. 118 1993 860 864
3. J.L. Gomez A. Dupont L. Cusan Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients Am J Med. 92 1992 465 470
4. ASHP therapeutic position statement on the use of the International Normalized Ratio system to monitor oral anticoagulant therapy Am J Health Syst Pharm. 52 1995 529 531
5. V.M. Wilt J.G. Gums O.I. Ahmed Outcome analysis of a pharmacistmanaged anticoagulation service Pharmacotherapy. 15 1995 732 739
6. K.G. Jozefczyk P.J. Schneider O.S. Pathak Medication errors in a pharmacy ·coordinated drug administration program Am J Hosp Pharm. 43 1986 2464 2467
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel II) JAMA. 269 1993 3015 3023 6
8. J.M. McKenney Understanding and treating dyslipidemia associated with non-insulin-dependent diabetes mellitus and hypertension Pharmacotherapy. 13 1993 240 352
9. M.E. Laski Diuretics: mechanism of action and therapy Sem Nephrol. 6 1986 210 233
10. O.W. Cockcroft M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron. 16 1976 31 41
11. Young L YY, Koda-Kimble MA. Applied Therapeutics: The Clinical Use of Drugs. 6th ed. Vancouver: Applied Therapeutics, Inc.; 4-1-20.
12. F. Apple C. Bandt A. Prosch Creatinine clearance: enzymatic vs Jaffe determinations of creatinine in plasma and urine Clin Chem. 32 1986 388 390
13. O.W. Nierenberg Measuring drug levels in the office: rationale, possible advantages, and potential problems Med Clin North Amer. 71 1987 653 664